OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
): Outsourcing method development offers multiple benefits to companies.
Biologic drugs used in clinical trials need technologies to meet the unique requirements of each study.
Certain high-value sterile dosage forms pose fill/finish challenges due to the small batch sizes
April 23, 2021
Executives that participated in the CPhI post-pandemic survey are predicting a push for repatriation of manufacturing globally.
April 21, 2021
Post-inspection report reveals nine sanitary and process problems at Bayview, Md., facility.
April 09, 2021
Even before Emergent disclosed that it had to discard 15 million doses of the J&J vaccine drug substance, FDA inspectors had uncovered multiple deficiencies and quality control issues.
April 05, 2021
Following a manufacturing mix-up, J&J will extend its oversight at Emergent’s Maryland facility; AstraZeneca manufacturing to relocate.
April 03, 2021
Intensified and distributed manufacturing approaches create flexible, local capacity.
April 02, 2021
The availability of materials is a critical factor when it comes to vaccine capacity.
March 30, 2021
SGS is supporting Selecta Biosciences and Asklepios BioPharmaceutical with the Phase I dose-escalation trial of SEL-3999, an AAV8 vector capsid containing no transgene with ImmTOR.
Celonic will manufacture CvnCoV at its facility in Germany.
March 25, 2021
Stelis Biopharma has closed its Series B and Series C fundraise for US $195 million, which will be used to progress the company’s growth initiatives and help scale its business.
March 18, 2021
An integrated CMC provider can help smaller companies to streamline development timelines and reduce project management complexity when compared with multi-provider models.